The Scientist

» immunotherapy

Most Recent

image: Two-Faced Proteins May Tackle HIV Reservoirs

Two-Faced Proteins May Tackle HIV Reservoirs

By Amanda B. Keener | October 21, 2015

Researchers design antibody-like proteins to awaken and destroy HIV holdouts.

0 Comments

image: Biotech Buys Autoimmune Firm for $7B

Biotech Buys Autoimmune Firm for $7B

By Kerry Grens | July 16, 2015

Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.

0 Comments

image: Viral Immunotherapy for Melanoma

Viral Immunotherapy for Melanoma

By Kerry Grens | May 28, 2015

Phase 3 data from a clinical trial show a positive response to a melanoma treatment based on a modified herpesvirus.

0 Comments

image: <em>The Scientist</em> on the Pulse, April 23

The Scientist on the Pulse, April 23

By Kerry Grens | April 23, 2015

Hot topics in cancer research from the annual meeting of the American Association for Cancer Research

0 Comments

T-cell receptor repertoires could help researchers determine whether a certain treatment will work for a given cancer patient. 

0 Comments

image: HIV Antibody Therapy

HIV Antibody Therapy

By Jef Akst | April 8, 2015

Delivering antibodies to HIV-infected people can lower levels of the virus, a study shows.

0 Comments

image: Another CAR-T IPO

Another CAR-T IPO

By Jef Akst | April 6, 2015

Cellectis goes public for a whopping $228 million—nearly double the value the company filed for in February.

0 Comments

image: Personalized Cancer Vaccines

Personalized Cancer Vaccines

By Anna Azvolinsky | April 2, 2015

A dendritic cell vaccine targeting melanoma patients’ tumor-specific mutations can activate a broad range of cancer-fighting T cells. 

2 Comments

image: Cancer Immunotherapist

Cancer Immunotherapist

By Jef Akst | April 1, 2015

Scientist to Watch Yvonne Saenger explains recent advances in using biomarkers to identify cancer patients who might benefit most from immunotherapy.

1 Comment

image: The CAR T-Cell Race

The CAR T-Cell Race

By Vicki Brower | April 1, 2015

Tumor-targeting T-cell therapies are generating remarkable remissions in hard-to-beat cancers—and attracting millions of dollars of investment along the way.

2 Comments

Popular Now

  1. Stem Cell Vaccine Protects Mice From Cancer
  2. Nobel Prize–Winning Biologist Dies
  3. Sci-Hub Loses Domains and Access to Some Web Services
  4. CDC: Flu Vaccine 36 Percent Effective So Far
AAAS